BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by frankmanon May 13, 2022 10:34am

67 Views

Post# 34681366

Trades update

Time ET	Ex	Price	Change	Volume	Buyer	Seller
10:24:55	C	0.11	0.005	1,000	2 RBC	1 Anonymous
10:24:55	C	0.11	0.005	3,000	1 Anonymous	1 Anonymous
10:24:55	C	0.11	0.005	6,500	79 CIBC	1 Anonymous
10:24:55	C	0.11	0.005	2,500	1 Anonymous	1 Anonymous
10:24:55	C	0.11	0.005	3,500	1 Anonymous	2 RBC
10:24:55	C	0.11	0.005	13,500	1 Anonymous	79 CIBC
09:53:05	U	0.11	0.005	10,000	1 Anonymous	2 RBC
09:53:02	U	0.11	0.005	8,000	80 National Bank	1 Anonymous
09:53:02	U	0.11	0.005	2,000	80 National Bank	1 Anonymous
09:52:56	O	0.11	0.005	10,000	80 National Bank	1 Anonymous